Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
LAURUSLABS

Laurus Labs Share Price

 

 

Laurus Labs live price: ₹1381.7. It opened at ₹1,370 vs previous close ₹1,374; intraday high/low: ₹1,392/₹1,365. The 50 & 200 DMA stand at ₹1,185.91/₹1,008.43.

Laurus Labs Performance

  • Today's Low
  • ₹1,365
  • Today's High
  • ₹1,392
  • 52 Week Low
  • ₹594
  • 52 Week High
  • ₹1,392
  • Open Price₹1,370
  • Previous Close₹1,374
  • Volume1,311,180
  • 50 DMA₹1,185.91
  • 100 DMA₹1,109.72
  • 200 DMA₹1,008.43

Laurus Labs Chart

Investment Returns

  • Over 1 Month + 22.98%
  • Over 3 Month + 28.43%
  • Over 6 Month + 37.73%
  • Over 1 Year + 129.59%

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 83.9
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 74,592
  • P/B Ratio
  • 14.7
  • Average True Range
  • 31.4
  • EPS
  • 16.46
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 65.11
  • RSI
  • 80.7
  • MFI
  • 94.1

Latest Stock News Updates

Laurus Labs rallies 6%, hits record high post Q4 results; brokerages upbeat

Laurus Labs is now getting the benefit of the same as the CDMO quarterly run rate has gone up from 220-250 crore to 450-500 crore in two years, believe analysts.

Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%

Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore. Full-year net profit surged 148% to Rs 889 crore, driven by strong growth in its CDMO and Generics divisions. The company also announced an interim dividend of Rs 1.20 per share.

Laurus Labs Results Earnings Call for Q4FY26 & Full Year

Conference Call with Laurus Labs Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹1,381.70
+ 7.8 (0.57%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,284.94
  • 50 Day
  • ₹1,185.91
  • 100 Day
  • ₹1,109.72
  • 200 Day
  • ₹1,008.43

Resistance and Support

1379.43 Pivot Speed
  • R3 1,420.17
  • R2 1,405.83
  • R1 1,393.77
  • S1 1,367.37
  • S2 1,353.03
  • S3 1,340.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 6,812.90 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 17% is great, ROE of 16% is good. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 21% and 36% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 21% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 62 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-30 Audited Results & Interim Dividend
2026-01-23 Quarterly Results
2025-10-23 Quarterly Results & Interim Dividend
2025-07-25 Quarterly Results
2025-04-24 Audited Results & Interim Dividend
Date Purpose Remarks
2026-05-08 INTERIM Rs.1.20 per share(60%)Interim Dividend
2025-10-31 INTERIM Rs.0.80 per share(40%)Interim Dividend
2025-05-09 INTERIM Rs.0.80 per share(40%)Second Interim Dividend
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
View Laurus Labs Dividend History Arrow

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.49%
11.22%
1.5%
25.82%
0%
21.25%
12.72%

Laurus Labs FAQs

Laurus Labs share price is ₹1,381 As on 29 May, 2026 | 05:25

The Market Cap of Laurus Labs is ₹74592 Cr As on 29 May, 2026 | 05:25

The P/E ratio of Laurus Labs is 83.9 As on 29 May, 2026 | 05:25

The PB ratio of Laurus Labs is 14.7 As on 29 May, 2026 | 05:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23